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G-protein coupled receptors (GPCRs)
are ubiquitous. Their role in communi-
cating extracellular events across the cell
membrane is essential and has not been
overlooked by those interested in the
processes of signal transduction and by
those attracted to manipulating signal
pathways for disease therapy. The nature
of GPCRs makes them suitable targets
for drug therapy for a number of reasons.
Depending on the signal pathway and
the desired physiological response, they
can be activated (agonists) or blocked
(antagonists). The ligand binding site is
accessible from the extracellular envi-
ronment, thereby not requiring drugs to
be able to enter the cell. Receptor sub-
type homology enables the development
of ligands having a balanced effect by
interacting equally with each subtype. In
addition, receptor subtype heterology
holds promise for the ability to exquis-
itely tune ligand specificity for particular
tissues and particular physiological re-
sponses. During the last 5 years or so,
there have been significant advances in
our understanding of the details of the
manner in which hormones such as an-
giotensin II and epinephrine bind to
GPCRs. The liaison between molecular
biology and medicinal chemistry in this
area has given birth to the concept of a
ligand binding site, which is conserved
among a great number of GPCRs and
can be used by antagonists to block the
effects of the endogenous agonist. In ad-
dition, we are beginning to understand
the biochemical processes involved with
agonist activation, signal transduction,
constitutive activity, and so forth. How-
ever, there is a paucity of structural in-
formation on this important class of in-
tegral membrane receptors. Our current
understanding in the areas of ligand
binding and signal transduction in
GPCRs comes from the familiar scien-
tific process of deductive reasoning. This
understanding has been developed with-
out the benefit of atomic resolution detail
obtained from x-ray diffraction or NMR
studies. Recent work by Herzyk and
Hubbard entitled "An Automated
Method for Modeling Seven-Helix
Transmembrane Receptors from Exper-
imental Data" published in this issue of
the Biophysical Journal, makes signifi-
cant advances in building three-dimen-
sional models of GPCRs that are consis-
tent with the results of seemingly
disparate experiments, a process not un-
like the popular guessing game "Twenty
Questions" (von Heijne, 1995).
Scientific opinion from some quar-
ters maintains that the biological mys-
teries of ligand-receptor interaction
and the chemical and conformational
response of the receptor to these pre-
cise but subtle events must await the
determination of a high resolution x-
ray or NMR structure. However, struc-
tural determination of GPCRs is diffi-
cult, mainly because large membrane-
bound proteins depend so critically on
the surrounding lipid bilayer and the
lipid-water interface for both their
structure and their function. In a very
real sense, the function of integral
membrane proteins such as GPCRs re-
quires the intimate association with the
lipid bilayer that complicates the more
traditional methods of structure deter-
mination and interpretation. It would
be difficult to appreciate the scale of
the heroic efforts that would be re-
quired from hordes of x-ray crystallog-
raphers and NMR spectroscopists to
understand the details of such complex
events as agonist binding, G-protein
binding, the allosteric reaction of the
receptor to the presence of either ago-
nist or G-protein, and the processes of
signal transduction. Nonetheless, re-
search efforts in these areas are ongo-
ing and undoubtedly will eventually
bear fruit. Fortunately, we may not
need to await the outcome of this ef-
fort. Recent advances in the area of
protein homology modeling have en-
abled the development of structural hy-
potheses that attempt to unify much of
the available experimental data, and
they can be used as a framework for
designing additional experiments and
can provide a basis for understanding
the biochemical processes involved.
The key to building such models lies in
the interpretation of experimental data,
such as the effects on ligand binding of
chimeric receptors and site-directed mu-
tant receptors, fluorescence quenching,
NMR (REDOR), site-di-rected spin la-
beling, etc. In general, these are simpler
experiments than those required for
high-resolution structure determination,
but they will (almost) always yield less
three-dimensional information; the task
confronting us then is to weave these
threads of information into a fabric of
understanding. Herzyk and Hubbard de-
scribe a strategy whereby they interpret
the results of mutational experiments,
biophysical experiments, sequence anal-
ysis, and protein structure comparison as
distance restraints or constraints between
the helical domains of GPCRs. By using
a rule-based automated method employ-
ing a Monte Carlo, simulated annealing
procedure, they derive "footprints" of
the heptahelical protein that conform to
these data. As described in their article,
this method satisfactorily generates the
observed electron diffraction footprints
of bacteriorhodopsin and rhodopsin.
Considering the amount of information
used in the model generation, their re-
sults are at the same time startling and
heartening.
The challenge is clear: advances in
the structure-based design and discov-
ery of drugs demand that we invest
intellectually in ways of exploiting the
deluge of genetic information from
various genome-sequencing projects
through automated structure-building
methods. Although the work of Herzyk
and Hubbard addresses the structures
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of bacteriorhodopsin and rhodopsin,
the implications for their methodology
to protein homology modeling are far-
reaching. Doolittle (1995) recently re-
viewed domain organization of protein
structure, and he defines domains as
those parts of a protein that can fold
independently of neighboring sequences.
Put another way, these structural do-
mains provide building blocks for pro-
tein structure; in turn, helices, (3 sheets,
turns, and loops can be considered build-
ing blocks of the structural domains. The
current rate of discovery of new protein
structural families and structural do-
mains suggests that although the number
of protein sequences seems almost un-
ending, a finite number of structural and
functional domains can be assembled in
various ways to form the cellular protein
machinery (Chothia and Taylor, 1994;
Murzin et al., 1995). Therefore auto-
mated methods of homology modeling
such as those described by Herzyk and
Hubbard show great potential in en-
abling worthy protein models to be built
from their building blocks. These meth-
ods help lay the foundation for the next
big revolution, from sequence to protein
structure (other important contributions
in this area have been reviewed recently
by Eisenhaber et al., 1995). The signifi-
cance of the work of Herzyk and Hub-
bard lies in the manner in which they use
disparate experimental data to refine a
protein model to within 1.9 A of the
electron diffraction structure, whereas
each datum poorly determines the struc-
tural possibilities; when taken together,
they provide powerful structural re-
straints. With these models in hand, ex-
periments can be designed to test the
various structural hypotheses or models.
What is lacking are the experimental strat-
egies that directly address ways of recog-
nizing and defining structural domains and
that probe the many ways in which these
domains might assemble in three dimen-
sions. The all-or-none philosophy ofmany
stnctural biologists might have to be tem-
pered as the structunal problems become
more difficult, as tie biological processes
become more complex, and importantly,
as the potential of hree-dimensional mod-
els is recognized.
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